Inari Medical, Inc. revised revenue guidance for the year 2023. For the full year 2023, the company is raising revenue guidance to a range of $490 million to $493 million, an increase of $4.5 million at the midpoint from prior guidance range of $482 million to $492 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.9 USD | -2.09% |
|
-7.24% | -29.30% |
05-23 | Sector Update: Health Care Stocks Lower Thursday Afternoon | MT |
05-23 | Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.30% | 2.73B | |
+75.69% | 12.57B | |
-25.26% | 7.43B | |
+14.20% | 7.04B | |
+15.12% | 5.64B | |
-17.16% | 4.84B | |
+16.16% | 4.22B | |
-24.07% | 3.84B | |
+2.85% | 2.11B | |
+9.75% | 2.01B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Revises Revenue Guidance for the Year 2023